Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents-Reference-Cited by-同舟云学术

Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents

Published:2021-03-11 Issue:5 Volume:28 Page:728-738
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Vergara Mercedes¹²³^ORCID,Miquel Mireia¹²³,Vela Emili⁴,Cleries Montserrat⁴,Pontes Caridad⁵⁶,Prat Alba⁵,Rué Montse⁷

Affiliation:

1. Unitat d’Hepatologia Servei d’Aparell Digestiu Parc Taulí Sabadell Hospital Universitari Institut d’Investigació i Innovació I3PT Universitat Autònoma de Barcelona Sabadell Barcelona Spain

2. Departament de Medicina Universitat Autònoma de Barcelona Sabadell Barcelona Spain

3. CIBERehd Instituto Carlos III Madrid Spain

4. Unitat d’informació i Coneixement Servei Català de la Salut Barcelona Spain

5. Gerència del Medicament Àrea Assistencial Servei Català de la Salut Barcelona Spain

6. Departament de Farmacologia, de Terapèutica i de Toxicologia Universitat Autònoma de Barcelona Sabadell Barcelona Spain

7. Basic Medical Sciences Department University of Lleida Lleida Spain

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13479

Reference34 articles.

1. EASL Recommendations on Treatment of Hepatitis C 2018

2. Fibrosis and disease progression in hepatitis C

3. Natural history of HCV infection

4. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis

5. Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data